Adam DeVore

Associate Professor

Duke University School of Medicine

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Adam DeVore is an Associate Professor at Duke University School of Medicine in the United States. His research focuses on novel donor heart preservation modalities, transplant procedures including Shone's Syndrome, and the management of donor-derived infections in organ transplantation. Additionally, he explores digital solutions for enhancing pharmacologic therapy for heart failure and the outcomes of ex vivo heart perfusion techniques in transplantation.

Articles (20)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Professor and CoDirector Cardiothoracic ICU

Duke University School of Medicine

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Adam DeVore

Research Interests

Explore related searches

Contact this professor

About

Articles (20)

Ensuring access to novel donor heart preservation modalities

Shone's Syndrome and Transplant

Hepatitis B Virus NAT Positive Donors in Non‐Hepatic Organ Transplant: Quantifying Viral Loads to Optimize Recipient Risk Stratification and Management in the Prevention of Donor‐Derived Infection

Failure to Launch

Moving From Prompts to Praxis With Remote Monitoring

Digital Solutions for the Optimization of Pharmacologic Therapy for Heart Failure

Finerenone for Prevention of First-Detected AF Across the Cardio-Kidney-Metabolic Spectrum

Utilization and Outcomes of Ex Vivo Heart Perfusion in Donation After Brain Death Heart Transplantation

A Digital Platform to Optimize Guideline-Directed Heart Failure Therapy: Rationale and Design of the AIM-POWER Trial

Metabolic and Pharmacokinetic Profiling of a Ketone Ester by Background SGLT2 Inhibitor Therapy in HFrEF

LMNA Cardiomyopathy: Important Considerations for the Heart Failure Clinician

The Promise and Risks of mHealth in Heart Failure Care

Patterns of Referral and Postdischarge Utilization of Cardiac Rehabilitation Among Patients Hospitalized With Heart Failure: An Analysis From the GWTG-HF Registry

When you need to dive in the deep end—Transplanting SARS‐CoV‐2 PCR+ recipients

Patients hospitalized with acute heart failure, worsening renal function, and persistent congestion are at high risk for adverse outcomes despite current medical therapy

Patient Perspectives on Digital Interventions to Manage Heart Failure Medications: The VITAL-HF Pilot

Inhaled Epoprostenol Compared With Nitric Oxide for Right Ventricular Support After Major Cardiac Surgery

Health care resource utilization and clinical outcomes for adult heart transplant recipients with primary graft dysfunction

Variation among organ procurement organizations in experience and practice of heart donation after circulatory death

Beyond Stage C: Considerations in the Management of Patients With Heart Failure Progression and Gaps in Evidence

Collaborators (9)

Neil Keshvani

Nicole Solomon

Alina Nicoara

Clyde Yancy

Sudarshan Rajagopal

Kamrouz Ghadimi

Gregg C Fonarow

Marc D. Samsky

Jerrold Levy

Make your next move.